Primary information |
---|
ID | antitb_1140 |
Peptide Name | LLKKK-18 |
Sequence | KEFKRIVKRIKKFLRKL |
N-terminal Modification | Free |
C-terminal Modification | Free |
Chemical Modification | None |
Linear/ Cyclic | Linear |
Length | 17 |
Chirality | L |
Nature | Amphipathic |
Source | Protein Derived |
Origin | Variant of LL-37 |
Species | Mycobacterium smegmatis |
Strain | Mycobacterium smegmatis mc2155 (ATCC 700084) |
Inhibition Concentartion | 25 μg of LLKKK-18/ml killed >80% of M. smegmatis after 24 h |
In vitro/In vivo | In vitro |
Cell Line | RAW264.7 |
Inhibition Concentartion | No significant reduction in intracellular survival of M. smegmatis was observed |
Cytotoxicity | No significant reduction in cell viability upto 25 μg/ml |
In vivo Model | None |
Lethal Dose | NA |
Immune Response | NA |
Mechanism of Action | Permeabilization of the bacterial cell membrane |
Target | Cell envelope |
Combination Therapy | None |
Other Activities | None |
Pubmed ID | 23689720 |
Year of Publication | 2013 |
3-D Structure | View in Jmol or Download Structure |